logo

Bioxcel Therapeutics, Inc. (BTAI)



Trade BTAI now with
  Date
  Headline
6/16/2020 7:13:45 AM BioXcel Therapeutics Appoints William Kane As Chief Commercial Officer
6/11/2020 7:07:07 AM BioXcel Says First Patient Enrolled In Phase 1b/2 RELEASE Trial Of BXCL501 For Treatment Of Opioid Withdrawal Symptoms
5/12/2020 7:14:33 AM BioXcel Therapeutics Q1 Net Loss $14.9 Mln Vs Loss $7.2 Mln Last Year
2/20/2020 7:37:49 AM BioXcel Therapeutics Prices Public Offering Of 2 Mln Shares At $32/Shr
1/7/2020 7:06:01 AM BioXcel Therapeutics Enrolls First Patient In Phase 1b/2 Study Of BXCL501